日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS

tafasitamab 与 CD19 的结合可提高 CART19 细胞疗法的治疗指数并减轻 CRS 的严重程度。

Sakemura, R Leo; Manriquez Roman, Claudia; Horvei, Paulina; Siegler, Elizabeth L; Girsch, James H; Sirpilla, Olivia L; Stewart, Carli M; Yun, Kun; Can, Ismail; Ogbodo, Ekene J; Adada, Mohamad M; Bezerra, Evandro D; Kankeu Fonkoua, Lionel Aurelien; Hefazi, Mehrdad; Ruff, Michael W; Kimball, Brooke L; Mai, Long K; Huynh, Truc N; Nevala, Wendy K; Ilieva, Kristina; Augsberger, Christian; Patra-Kneuer, Maria; Schanzer, Jürgen; Endell, Jan; Heitmüller, Christina; Steidl, Stefan; Parikh, Sameer A; Ding, Wei; Kay, Neil E; Nowakowski, Grzegorz S; Kenderian, Saad S

Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapy.

Tafasitab 与 α1T 细胞或同种异体 NK 细胞疗法联合使用,可杀伤 B 细胞非霍奇金淋巴瘤

Her Jung Hyun, Pretscher Dominik, Patra-Kneuer Maria, Schanzer Juergen, Cho Sung Yoo, Hwang Yu Kyeong, Hoeres Timm, Boxhammer Rainer, Heitmueller Christina, Wilhelm Martin, Steidl Stefan, Endell Jan

α-Radioimmunotherapy with ²¹³Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myeloma

使用²¹³Bi-抗CD38免疫偶联物的α放射免疫疗法在人类多发性骨髓瘤小鼠模型中有效。

Teiluf, Katharina; Seidl, Christof; Blechert, Birgit; Gaertner, Florian C; Gilbertz, Klaus-Peter; Fernandez, Vanesa; Bassermann, Florian; Endell, Jan; Boxhammer, Rainer; Leclair, Stephane; Vallon, Mario; Aichler, Michaela; Feuchtinger, Annette; Bruchertseifer, Frank; Morgenstern, Alfred; Essler, Markus

Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking

绿色荧光蛋白标记的腺相关病毒颗粒可用于研究胞质和核内的转运。

Lux, Kerstin; Goerlitz, Nico; Schlemminger, Stefanie; Perabo, Luca; Goldnau, Daniela; Endell, Jan; Leike, Kristin; Kofler, David M; Finke, Stefan; Hallek, Michael; Büning, Hildegard